Arunkumar Bapurao Biradar, Arun Das, Pratibha Prakash
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Introduction: Normal Intra Ocular Pressure ranges from 14 – 21 mm of Hg Ocular Hypertension is an asymptomatic condition with raised Intra Ocular Pressure without any visual impairment or comorbidities. Altered Intra Ocular Pressure above/below normal level with associated reduced peripheral vision & optic neuropathy are referred to as glaucoma. OHT population is at greater risk of developing glaucoma. They remain unnoticed and undiagnosed most of the time for a longer duration or advancement of the condition. Early diagnosis and timely management prevent the progression of the disease to Primary Open Angle Glaucoma and other conditions considering this scenario, Sadyovirechana with Avipattikara Churna was tried in a group of patients to evaluate its effect over IOP.
Materials & Methods: 300 patients were screened from the eye Out Patient Department of institute. 10 Patients fulfilled the inclusion criteria were enrolled and analysed for results. Avipattikara Churna was administered orally and the efficacy was analysed for results. The assessment of Intra Ocular Pressure was done with the help of Goldman’s Applanation Tonometry.
Results: For statistical analysis t test was used. Within the group, there was a significant reduction of Intra Ocular Pressure with a p-value <0.0001.
Conclusion: There was significant reduction in the values of Intra Ocular Pressure and a nearly normal value was achieved as target Intra Ocular Pressure.
Arun Das, Arunkumar Bapurao Biradar, Pratibha Prakash. Effect of Sadhyovirechana in Occular Hpertension: A Pilot Study. Indian J Ancient Yoga. 2023;16(3):125-128 ¹.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| April 03, 2023 | April 26, 2023 | May 30, 2023 |
Monday 13 July 2026, 13:52:20 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | April 03, 2023 |
| Accepted | April 26, 2023 |
| Published | May 30, 2023 |
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.